• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Meet the Board: AffirmedRx CEO Greg Baker Unveils Game-Changing Strategy for PBM Industry


As we bring back Managed Healthcare Executive's "Meet the Board" podcast series, MHE welcomes its newest Editorial Advisory Board member Greg Baker, CEO of AffirmedRx.

As we bring back our "Meet the Board" Series podcast series, Managed Healthcare Executive welcomes our newest Editorial Advisory Board member Greg Baker, CEO of AffirmedRx. In this conversation, Baker and Peter Wehrwein, MHE managing editor, discussed insights from Baker's career journey, particularly his tenure at Walgreens, where he gained insights into operational efficiency and patient care.

Baker highlighted the importance of process orientation and patient-centered care, drawing from his experience as a pharmacist.



He also dove into his time at Premise Health, highlighting their service-oriented model focused on improving adherence and patient outcomes. He contrasted this with traditional PBMs' profit-driven approaches, expressing concerns about opaque pricing practices and exclusionary formularies.

AffirmedRx, a public benefit corporation, aims to bring transparency to the PBM industry by disclosing all financial terms to clients. Baker discussed their unique approach, which includes a cloud-based system, patient care advocates, and a clinically-driven formulary that prioritizes cost-effectiveness and clinical utility over rebates.

He expressed skepticism about legislative solutions, suggesting that current proposals may not address the root causes of industry issues. AffirmedRx is part of TransparencyRx, a collective advocating for industry reform.

Looking ahead, Baker warned against the proliferation of corporate entities within PBMs, which could further obscure pricing practices and hinder transparency efforts. He underscored the importance of educating stakeholders and advocating for meaningful reform within the industry.

Related Videos
Video 6 - "Navigating Insurance Coverage for Prescription Digital Therapeutics"
Video 5 - "FDA Approval Pathway for Prescription Digital Therapeutics"
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
Related Content
© 2024 MJH Life Sciences

All rights reserved.